• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性黄斑水肿的治疗:在治疗糖尿病眼病所致视力损害方面实现最佳患者管理

Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease.

作者信息

Gale R, Scanlon P H, Evans M, Ghanchi F, Yang Y, Silvestri G, Freeman M, Maisey A, Napier J

机构信息

The Action on DMO group, UK.

The York Hospital, York, UK.

出版信息

Eye (Lond). 2017 May;31(S1):S1-S20. doi: 10.1038/eye.2017.53.

DOI:10.1038/eye.2017.53
PMID:28490797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5437340/
Abstract

This paper identifies best practice recommendations for managing diabetes and sight-threatening diabetic eye disease. The authors provide an update for ophthalmologists and allied healthcare professionals on key aspects of diabetes management, supported by a review of the pertinent literature, and recommend practice principles for optimal patient management in treating visual impairment due to diabetic eye disease. In people with diabetes, early optimal glycaemic control reduces the long-term risk of both microvascular and macrovascular complications. The authors propose more can and should be done to maximise metabolic control, promote appropriate behavioural modifications and encourage timely treatment intensification when indicated to ameliorate diabetes-related complications. All people with diabetes should be screened for sight-threatening diabetic retinopathy promptly and regularly. It is shown that attitudes towards treatment adherence in diabetic macular oedema appear to mirror patients' views and health behaviours towards the management of their own diabetes. Awareness of diabetic macular oedema remains low among people with diabetes, who need access to education early in their disease about how to manage their diabetes to delay progression and possibly avoid eye-related complications. Ophthalmologists and allied healthcare professionals play a vital role in multidisciplinary diabetes management and establishment of dedicated diabetic macular oedema clinics is proposed. A broader understanding of the role of the diabetes specialist nurse may strengthen the case for comprehensive integrated care in ophthalmic practice. The recommendations are based on round table presentations and discussions held in London, UK, September 2016.

摘要

本文确定了糖尿病及威胁视力的糖尿病眼病管理的最佳实践建议。作者在对相关文献进行综述的支持下,为眼科医生及相关医疗保健专业人员提供了糖尿病管理关键方面的最新信息,并推荐了在治疗糖尿病眼病所致视力损害时进行最佳患者管理的实践原则。在糖尿病患者中,早期实现最佳血糖控制可降低微血管和大血管并发症的长期风险。作者提出,可以并且应该采取更多措施来最大限度地实现代谢控制,促进适当的行为改变,并在有指征时鼓励及时加强治疗以改善糖尿病相关并发症。所有糖尿病患者都应及时且定期筛查是否患有威胁视力的糖尿病视网膜病变。研究表明,糖尿病性黄斑水肿患者对治疗依从性的态度似乎反映了患者对自身糖尿病管理的看法和健康行为。糖尿病患者对糖尿病性黄斑水肿的认识仍然较低,他们需要在疾病早期就获得关于如何管理糖尿病以延缓病情进展并可能避免眼部相关并发症的教育。眼科医生及相关医疗保健专业人员在多学科糖尿病管理中发挥着至关重要的作用,本文建议设立专门的糖尿病性黄斑水肿诊所。对糖尿病专科护士作用的更广泛理解可能会加强眼科实践中全面综合护理的理由。这些建议基于2016年9月在英国伦敦举行的圆桌会议的报告和讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/f334729c81be/eye201753f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/d76e3285b7c0/eye201753f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/77bcc7079484/eye201753f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/bc7bd62f02f0/eye201753f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/363fed4ead44/eye201753f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/f334729c81be/eye201753f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/d76e3285b7c0/eye201753f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/77bcc7079484/eye201753f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/bc7bd62f02f0/eye201753f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/363fed4ead44/eye201753f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae14/5437340/f334729c81be/eye201753f5.jpg

相似文献

1
Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease.糖尿病性黄斑水肿的治疗:在治疗糖尿病眼病所致视力损害方面实现最佳患者管理
Eye (Lond). 2017 May;31(S1):S1-S20. doi: 10.1038/eye.2017.53.
2
Management of diabetic macular edema in Japan: a review and expert opinion.日本糖尿病性黄斑水肿的管理:综述与专家意见
Jpn J Ophthalmol. 2018 Jan;62(1):1-23. doi: 10.1007/s10384-017-0537-6. Epub 2017 Dec 5.
3
Diabetic eye disease: A review of screening and management recommendations.糖尿病眼病:筛查和管理建议综述。
Clin Exp Ophthalmol. 2021 Mar;49(2):128-145. doi: 10.1111/ceo.13894. Epub 2021 Jan 10.
4
[Diagnosis, treatment and monitoring of diabetic eye disease (Update 2023)].糖尿病眼病的诊断、治疗及监测(2023年更新)
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):195-200. doi: 10.1007/s00508-022-02119-7. Epub 2023 Apr 20.
5
Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy.患者对一种新的监测途径的看法,该途径涉及经过培训的非医疗人员,适用于患有治疗性糖尿病性黄斑水肿和增生性糖尿病性视网膜病变的患者。
Eye (Lond). 2023 Apr;37(6):1155-1159. doi: 10.1038/s41433-022-02050-1. Epub 2022 May 6.
6
Diabetic macular oedema: clinical risk factors and emerging genetic influences.糖尿病性黄斑水肿:临床危险因素及新出现的遗传影响
Clin Exp Optom. 2017 Nov;100(6):569-576. doi: 10.1111/cxo.12552. Epub 2017 May 26.
7
Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetes.妊娠导致的 1 型糖尿病女性视力威胁性糖尿病视网膜病变。
Diabet Med. 2010 Apr;27(4):431-5. doi: 10.1111/j.1464-5491.2010.02958.x.
8
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study.多模态成像由分级员解读,以检测先前治疗过的糖尿病眼病患者的再激活:EMERALD 诊断准确性研究。
Health Technol Assess. 2021 May;25(32):1-104. doi: 10.3310/hta25320.
9
Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.降脂药物与美国糖尿病患者视网膜病变和眼科干预风险降低相关。
Am J Ophthalmol. 2019 Nov;207:378-384. doi: 10.1016/j.ajo.2019.05.029. Epub 2019 Jun 10.
10
Diabetic macular edema.糖尿病性黄斑水肿
Ophthalmology. 2012 Dec;119(12):2643.e1. doi: 10.1016/j.ophtha.2012.07.075.

引用本文的文献

1
A Comparison of Ultra-Widefield Imaging Quality Obtained with Zeiss Clarus and Optos for Virtual Medical Retina Services.蔡司Clarus和Optos用于虚拟医学视网膜服务的超广角成像质量比较
J Clin Med. 2025 May 8;14(10):3270. doi: 10.3390/jcm14103270.
2
Health economics of virtual versus face-to-face glaucoma clinics: a time-driven activity-based costing study.虚拟与面对面青光眼诊所的卫生经济学:基于时间的活动成本核算研究。
BMJ Open Ophthalmol. 2024 Nov 28;9(1):e001800. doi: 10.1136/bmjophth-2024-001800.
3
Associated factors of diabetic retinopathy in type 1 and 2 diabetes in Limpopo province in South Africa.

本文引用的文献

1
Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database.老年2型糖尿病患者的依从性与治疗结果之间的关联:来自医疗保险补充数据库的证据。
Patient Prefer Adherence. 2016 Aug 16;10:1573-81. doi: 10.2147/PPA.S107543. eCollection 2016.
2
An internet-based intervention with brief nurse support to manage obesity in primary care (POWeR+): a pragmatic, parallel-group, randomised controlled trial.基于互联网的干预措施,辅以简短的护士支持,以在初级保健中管理肥胖症(POWeR+):一项实用、平行组、随机对照试验。
Lancet Diabetes Endocrinol. 2016 Oct;4(10):821-8. doi: 10.1016/S2213-8587(16)30099-7. Epub 2016 Jul 26.
3
南非林波波省1型和2型糖尿病患者糖尿病视网膜病变的相关因素
Front Clin Diabetes Healthc. 2024 May 2;5:1319840. doi: 10.3389/fcdhc.2024.1319840. eCollection 2024.
4
An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective.关注公平:从英国社会角度出发,采用分布成本效益分析,评估 faricimab 治疗糖尿病黄斑水肿对公平性的影响。
Eye (Lond). 2024 Jul;38(10):1917-1925. doi: 10.1038/s41433-024-03043-y. Epub 2024 Mar 30.
5
Multi-Scale-Denoising Residual Convolutional Network for Retinal Disease Classification Using OCT.基于 OCT 的视网膜病变分类的多尺度去噪残差卷积网络
Sensors (Basel). 2023 Dec 27;24(1):150. doi: 10.3390/s24010150.
6
Development and validation of a risk prediction model for visual impairment in older adults.老年人视力损害风险预测模型的开发与验证
Int J Nurs Sci. 2023 Jun 20;10(3):383-390. doi: 10.1016/j.ijnss.2023.06.010. eCollection 2023 Jul.
7
Subthreshold Micropulse Laser for Diabetic Macular Edema: A Review.阈下微脉冲激光治疗糖尿病性黄斑水肿:综述
J Clin Med. 2022 Dec 29;12(1):274. doi: 10.3390/jcm12010274.
8
Comparing Objective Perimetry, Matrix Perimetry, and Regional Retinal Thickness in Mild Diabetic Macular Edema.比较客观视野计、矩阵视野计和轻度糖尿病性黄斑水肿的局部视网膜厚度。
Transl Vis Sci Technol. 2021 Nov 1;10(13):32. doi: 10.1167/tvst.10.13.32.
9
Epidemiology of Ocular Manifestations in Autoimmune Disease.自身免疫性疾病眼部表现的流行病学。
Front Immunol. 2021 Nov 2;12:744396. doi: 10.3389/fimmu.2021.744396. eCollection 2021.
10
Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.德国眼科学会、德国视网膜学会和德国眼科医生专业协会关于糖尿病性黄斑水肿治疗的声明:日期为2019年8月。
Ophthalmologe. 2021 Jan;118(Suppl 1):40-67. doi: 10.1007/s00347-020-01244-w.
Visual Function, Social Position, and Health and Life Chances: The UK Biobank Study.
视觉功能、社会地位与健康及生活机遇:英国生物银行研究
JAMA Ophthalmol. 2016 Sep 1;134(9):959-66. doi: 10.1001/jamaophthalmol.2016.1778.
4
Nurse-led patient-centered self-management support improves HbA1c in patients with type 2 diabetes-A randomized study.由护士主导的以患者为中心的自我管理支持可改善2型糖尿病患者的糖化血红蛋白——一项随机研究。
Patient Educ Couns. 2016 Nov;99(11):1821-1829. doi: 10.1016/j.pec.2016.06.016. Epub 2016 Jun 17.
5
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.1980年以来全球糖尿病趋势:对751项基于人群的研究进行的汇总分析,涉及440万参与者。
Lancet. 2016 Apr 9;387(10027):1513-1530. doi: 10.1016/S0140-6736(16)00618-8. Epub 2016 Apr 6.
6
[Obstructive sleep apnea syndrome. Is it a risk factor for diabetic retinopathy?].[阻塞性睡眠呼吸暂停综合征。它是糖尿病视网膜病变的危险因素吗?]
J Fr Ophtalmol. 2016 Feb;39(2):139-42. doi: 10.1016/j.jfo.2015.08.014. Epub 2016 Feb 10.
7
Retinal Imaging Techniques for Diabetic Retinopathy Screening.用于糖尿病视网膜病变筛查的视网膜成像技术。
J Diabetes Sci Technol. 2016 Feb 1;10(2):282-94. doi: 10.1177/1932296816629491.
8
Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study.2000年至2013年基层医疗中2型糖尿病的发病率、患病率及处方趋势:一项回顾性队列研究。
BMJ Open. 2016 Jan 13;6(1):e010210. doi: 10.1136/bmjopen-2015-010210.
9
Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.开发用于优化糖尿病视网膜病变筛查间隔的成本效益模型。
Health Technol Assess. 2015 Sep;19(74):1-116. doi: 10.3310/hta19740.
10
Screening attendance, age group and diabetic retinopathy level at first screen.初次筛查时的筛查参与情况、年龄组及糖尿病视网膜病变程度。
Diabet Med. 2016 Jul;33(7):904-11. doi: 10.1111/dme.12957. Epub 2015 Oct 6.